Clinical Trial Update: Bevacizumab Versus Ranibizumab in Age Related Macular Degeneration [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing bevacizumab and ranibizumab for age-related macular degeneration.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Avastin (bevacizumab)
• Lucentis (ranibizumab)

Snippet

Sponsor: Instituto de Olhos de Goiania | Conditions: Age Related Macular Degeneration | Phase 3 | Status: UNKNOWN